Cargando...
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway
Diabetic nephropathy (DN) is the leading cause of end-stage failure of the kidney, but the efficacy of current strategies available for the prevention of DN remains unsatisfactory. The purpose of this study was to assess whether sitagliptin (SIT) has therapeutic potential for prevention of DN and to...
Guardado en:
| Publicado en: | Int J Mol Med |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
D.A. Spandidos
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5846674/ https://ncbi.nlm.nih.gov/pubmed/29484381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.3504 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|